The minimum dose of dexmedetomidine required for cessation of postspinal anesthesia shivering: A prospective observational study
Background and Aims: Shivering is a common postanesthesia adverse event with multiple etiologies. Dexmedetomidine, a centrally acting alpha-2 adrenergic agonist, is known to reduce the shivering threshold. However, the minimum dose at which dexmedetomidine causes cessation of shivering is unknown. T...
Enregistré dans:
| Auteurs principaux: | , |
|---|---|
| Format: | Livre |
| Publié: |
Wolters Kluwer Medknow Publications,
2017-01-01T00:00:00Z.
|
| Sujets: | |
| Accès en ligne: | Connect to this object online. |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Internet
Connect to this object online.3rd Floor Main Library
| Cote: |
A1234.567 |
|---|---|
| Exemplaire 1 | Disponible |